PTK2 and prostate carcinoma: The presence of hyaluronidase Hyal1 in prostate cancer-derived EVs stimulate the prostate stromal cell motility by engaging FAK-mediated integrin signaling, indicating that the elevated Hyal1 promotes prostate cancer progression [115].